New Hope For Multiple Sclerosis Sufferers

A drug which was developed in Cambridge and initially designed to treat a form of leukaemia has also proven effective against combating the debilitating neurological disease multiple sclerosis (MS).

The study, led by researchers from the University of Cambridge, has found that alemtuzumab not only stops MS from advancing in patients with early stage active relapsing-remitting multiple sclerosis (RRMS) but may also restore lost function caused by the disease. The findings were published today in the New England Journal of Medicine.

Category:

Education

Tags:

• Cambridge University
• Multiple Sclerosis
• MS
• Health
• Medecine
• Alemtuzumab
• Campath
• Science

[xxxpistolpetexxx]

:O sounds like progress is being made.

[Vivianne766]

You are trying to re-educate body's immune system without knowing WHY it behaves that way in the first place. CCSVI has a good explanation. Liberation therapy makes more sense doesn't it?

[STINGOALI]

So what is the 'trigger' for MS?

[Lynneheal]

Comment Pending Approval!

[STINGOALI]

My MS symptoms have almost gone after a simple angioplasty procedure in both of my internal jugular veins - treatment for CCSVI. About 13000 people worldwide with MS have been scanned and treated for CCSVI - 95% of these people have been found to have congenital venous malformations. Have a read of Tallantyre (Nottingham Univ) paper - Tesla 7 scanner shows that almost all MS lesions have veins at the centre of them. Why treat stenosed veins with a cancer drug????

[gekiryudojo]

more time more money no cure! then :( just another snake oil!

[zingzangwallawalla]

Nearly a year on from my first Campath infusion and I feel great.

My level of disability has definitely improved, as mentioned in this clip.

My bloods have all been fine since as well.

Thank you for giving me my life back :)

[MSVlogSupport]

This sounds good, but I have a question regarding all drug trials. Why is the brain the only thing being monitored? Most of my lesions and relapses have all been due to spinal cord lesions. Is it just assumed that if it works for the brain that it will work with the spinal cord?

[erinmludwig]

I was screened to be a part of the phase III clinical trial but one of my lab results was off and they closed the trial to participants before new blood work could be taken. This looks like its going to be the new gold standard in treatment. I would much prefer 3-5 days of IV treatment once a year over daily injections. I can't wait for the results.